Phase II

MaRS announced today (June 26, 2007) that it has selected Alexandria Real Estate Equities, Inc. (NYSE: ARE), North America’s pre-eminent, first-in-class and largest life science property specialist, as the development partner for an iconic new building which will anchor the city’s biomedical corridor in the Discovery District of Toronto. To be developed on a prominent street corner in Toronto at University Avenue and College Street, the building is adjacent to the seat of the provincial government, cultural and financial districts, and world-class academic and clinical research institutions. In this exceptional location, Alexandria will apply its renowned expertise in developing clusters, including its proprietary programmatic elements, to strengthen Toronto’s growing life science and technology cluster centered in the Discovery District. The influence and impact of MaRS on the local community, greater Ontario and Canada will grow exponentially through the strategic alliance with Alexandria.

PICTURES

Nearly 400 guests joined the Premier of Ontario, Mayor of Toronto and other dignitaries on June 26, 2007 to celebrate the announcement of MaRS' spectacular Phase II development with California-based Alexandria Real Estate Equities Inc.

Prevous image

3

/

4

Next image

View more Phase II announcement photos on Flickr

VIDEOS

• Event video - Broadband connection (mp4)
• Event video - Dial-up connection (mp4)

ABOUT ALEXANDRIA

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE:NYSE) is the largest owner and pre-eminent first-in-class international real estate operator focused principally on the ownership, operation, redevelopment, selective development and acquisition of properties containing office and laboratory space. Alexandria is the leading provider of real estate to the life science industry and has an outstanding almost ten-year track record as a NYSE listed company with an approximate $5.2 billion total market capitalization as of March 31, 2007. Alexandria provides high quality real estate, technical infrastructure, services, and capital to the broad and diverse life science sector. Client tenants include universities and not-for-profit institutions, pharmaceutical, biotechnology, medical device, life science product, service and translational research entities, as well as governmental agencies. Alexandria’s international operating platform is based on the principle of "clustering" with assets and operations strategically located and dominant in each key life science cluster submarket.

For Alexandria Real Estate Equities, Inc.
Judith Sylk-Siegel
Rx Communications Group
917-322-2164
jsylksiegel@rxir.com

PRESS RELEASES

• MaRS Selects Alexandria Real Estate Equities to Expand the MaRS Centre in the Discovery District of Toronto

Press Release [119 KB]

• Email Page
• Print Page
• Increase Font
• Decrease Font

MaRS FACTS

The MaRS Incubator currently houses 27 emerging companies in fields such as life sciences, communications, information technology and advanced materials.

MaRS PICKS

Read more